The Gut-Brain Axis: A Review of Microbial Metabolites in Neurotransmitter Synthesis and Neurodegenerative Disease Pathways
IFR Journal of Biochemistry and Biomedical Science · 24.02.2026 · 2 (1) · 1-10
DOI: 10.70146/bbsv02i01.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift IFR Journal of Biochemistry and Biomedical Science, erschienen am 24.02.2026. Verfasst von Debadulal Das Bidhar und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The gutbrain axis reflects a complicated two, way communication network connecting the gastrointestinal microbiota with the central nervous system via neural, immune, endocrine, and metabolic pathways. More andmore evidence is showing that metabolites produced by gut microbiota are essential players in the regulationof neurotransmitter synthesis and neurophysiological homeostasis, which in turn affects the development andprogression of neurodegenerative diseases. Here is a brief summary of the review article, the paper reviews andconsolidates current understanding of a number of microbial metabolites, such as short, chain fatty acids, tryptophan, derived compounds, bile acid derivatives, and neurotransmitter precursors, and it also studies their contributions to neurotransmitter modulation and neurodegenerative disease pathways. A thorough reviewof themost recent animal and human experiments shows that microbial imbalance correlates with disrupted metabolitepatterns, faulty neurotransmitter function, elevated neuroinflammation, and weakened bloodbrain barrier inAlzheimers disease and Parkinsons disease, among others. The micro, level study reveals howmicrobial metabolites influence microglial activation, oxidative stress, immune dysfunction, and protein misfolding, thuspointing to the systemic character of neurodegenerative illnesses. On the other hand, therapeutic approachesaimed at the gut microbiota, e.g., through changes in diet, antioxidant intake, targeted nutrition, and microbiome, related therapies, are quite effective in re, establishing metabolic homeostasis and decreasing the progressionof neurodegeneration. Overall, the scientific literature points to the gutbrain axis as a main factor in neurological health and a promising target for therapeutic intervention. Unraveling microbiota, driven metabolic signalingmechanisms could lead to new, individualized approaches for the prevention and treatment of neurodegenerative diseases.
Zitieren
APA
Bidhar, D. D., Singh, M. B., & Acharya, S. (2026). The Gut-Brain Axis: A Review of Microbial Metabolites in Neurotransmitter Synthesis and Neurodegenerative Disease Pathways. IFR Journal of Biochemistry and Biomedical Science, 2(1), 1-10. https://doi.org/10.70146/bbsv02i01.001
Vancouver
Bidhar DD, Singh MB, Acharya S. The Gut-Brain Axis: A Review of Microbial Metabolites in Neurotransmitter Synthesis and Neurodegenerative Disease Pathways. IFR Journal of Biochemistry and Biomedical Science. 2026;2(1):1-10. doi:10.70146/bbsv02i01.001
BibTeX
@article{Bidhar2026,
author = {Bidhar, Debadulal Das and Singh, Maheswar Bahubalendra and Acharya, Supriyo},
title = {The Gut-Brain Axis: A Review of Microbial Metabolites in Neurotransmitter Synthesis and Neurodegenerative Disease Pathways},
journal = {IFR Journal of Biochemistry and Biomedical Science},
year = {2026},
volume = {2},
number = {1},
pages = {1--10},
doi = {10.70146/bbsv02i01.001}
}
EUVIMED